AAAAAA

   
Results: 1-24 |
Results: 24
THE EFFECT OF INTRAVENOUS (IV) SDZ PSC833 (PSC) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DOXORUBICIN (DOX) IN A PHASE-I TRIAL
Authors: OHTSU T TANIGAWARA Y FUJII H MINAMI H IGARASHI T ITOH K ONOZAWA Y WATANABE Y KODAMA K MORIKAWA H SASAKI Y
Citation: T. Ohtsu et al., THE EFFECT OF INTRAVENOUS (IV) SDZ PSC833 (PSC) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DOXORUBICIN (DOX) IN A PHASE-I TRIAL, Annals of oncology, 9, 1998, pp. 552-552
UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN
Authors: FUSE E TANII H KURATA N KOBAYASHI H SHIMADA Y TAMURA T SASAKI Y TANIGAWARA Y LUSH RD HEADLEE D FIGG WD ARBUCK SG SENDEROWICZ AM SAUSVILLE EA AKINAGA S KUWAHARA A KOBASASHI S
Citation: E. Fuse et al., UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN, Cancer research, 58(15), 1998, pp. 3248-3253
ENHANCED ANTIINFLAMMATORY EFFECTS OF CU, ZN-SUPEROXIDE DISMUTASE DELIVERED BY GENETICALLY-MODIFIED SKIN FIBROBLASTS IN-VITRO AND IN-VIVO
Authors: OKUMURA K NISHIGUCHI K TANIGAWARA Y MORI S IWAKAWA S KOMADA F
Citation: K. Okumura et al., ENHANCED ANTIINFLAMMATORY EFFECTS OF CU, ZN-SUPEROXIDE DISMUTASE DELIVERED BY GENETICALLY-MODIFIED SKIN FIBROBLASTS IN-VITRO AND IN-VIVO, Pharmaceutical research, 14(9), 1997, pp. 1223-1227
PHARMACOKINETICS OF ADRIAMYCIN AND CISPLATIN FOR ANHEPATIC CHEMOTHERAPY DURING LIVER-TRANSPLANTATION
Authors: KU Y KUSUNOKI N KITAGAWA T MAEDA I FUKUMOTO T IWASAKI T TOMINAGA M SUZUKI Y KURODA Y TANIGAWARA Y SAITOH Y
Citation: Y. Ku et al., PHARMACOKINETICS OF ADRIAMYCIN AND CISPLATIN FOR ANHEPATIC CHEMOTHERAPY DURING LIVER-TRANSPLANTATION, Cancer chemotherapy and pharmacology, 40(6), 1997, pp. 457-462
CROSS-REACTIVITY OF TDX AND OPUS IMMUNOASSAY SYSTEMS FOR SERUM DIGOXIN DETERMINATION
Authors: OKAZAKI M TANIGAWARA Y KITA T KOMADA F OKUMURA K
Citation: M. Okazaki et al., CROSS-REACTIVITY OF TDX AND OPUS IMMUNOASSAY SYSTEMS FOR SERUM DIGOXIN DETERMINATION, Therapeutic drug monitoring, 19(6), 1997, pp. 657-662
RELATIONSHIPS BETWEEN P450 CYP2C19 GENOTYPE AND EFFICACY OF OMEPRAZOLE FOR THE TREATMENT OF HELICOBACTER-PYLORI INFECTION
Authors: TANIGAWARA Y KITA T AOYAMA N SHIRAKAWA K KOMADA F KASUGA M OKUMURA K
Citation: Y. Tanigawara et al., RELATIONSHIPS BETWEEN P450 CYP2C19 GENOTYPE AND EFFICACY OF OMEPRAZOLE FOR THE TREATMENT OF HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 308-308
GENOTYPING OF N-ACETYLATION POLYMORPHISM AND CORRELATION WITH PROCAINAMIDE METABOLISM
Authors: OKUMURA K KITA T CHIKAZAWA S KOMADA F IWAKAWA S TANIGAWARA Y
Citation: K. Okumura et al., GENOTYPING OF N-ACETYLATION POLYMORPHISM AND CORRELATION WITH PROCAINAMIDE METABOLISM, Clinical pharmacology and therapeutics, 61(5), 1997, pp. 509-517
RELATIONSHIP BETWEEN EXPRESSION LEVEL OF P-GLYCOPROTEIN AND DAUNORUBICIN TRANSPORT IN LLC-PK1 CELLS TRANSFECTED WITH HUMAN MDR1 GENE
Authors: TANAKA K HIRAI M TANIGAWARA Y UEDA K TAKANO M HORI R INUI K
Citation: K. Tanaka et al., RELATIONSHIP BETWEEN EXPRESSION LEVEL OF P-GLYCOPROTEIN AND DAUNORUBICIN TRANSPORT IN LLC-PK1 CELLS TRANSFECTED WITH HUMAN MDR1 GENE, Biochemical pharmacology, 53(5), 1997, pp. 741-746
PHARMACEUTICAL STUDIES FOR GENE-THERAPY - EXPRESSION OF HUMAN CU,ZN-SUPEROXIDE DISMUTASE GENE TRANSFECTED BY LIPOFECTION IN RAT SKIN FIBROBLASTS
Authors: NISHIGUCHI K ISHIDA K NAKAJIMA M MAEDA T KOMADA F IWAKAWA S TANIGAWARA Y OKUMURA K
Citation: K. Nishiguchi et al., PHARMACEUTICAL STUDIES FOR GENE-THERAPY - EXPRESSION OF HUMAN CU,ZN-SUPEROXIDE DISMUTASE GENE TRANSFECTED BY LIPOFECTION IN RAT SKIN FIBROBLASTS, Biological & pharmaceutical bulletin, 19(8), 1996, pp. 1073-1077
EFFECT OF TRANSFECTION WITH A SUPEROXIDE-DISMUTASE EXPRESSION PLASMIDON XANTHINE XANTHINE OXIDASE-INDUCED CYTOTOXICITY IN CULTURED RAT LUNG-CELLS/
Authors: KOMADA F NISHIGUCHI K TANIGAWARA Y WU XY IWAKAWA S OKUMURA K
Citation: F. Komada et al., EFFECT OF TRANSFECTION WITH A SUPEROXIDE-DISMUTASE EXPRESSION PLASMIDON XANTHINE XANTHINE OXIDASE-INDUCED CYTOTOXICITY IN CULTURED RAT LUNG-CELLS/, Biological & pharmaceutical bulletin, 19(8), 1996, pp. 1100-1102
EFFECT OF TRANSFECTION WITH SUPEROXIDE-DISMUTASE EXPRESSION PLASMID ON SUPEROXIDE ANION-INDUCED CYTOTOXICITY IN CULTURED RAT LUNG-CELLS
Authors: KOMADA F NISHIGUCHI K TANIGAWARA Y AKAMATSU T WU XY IWAKAWA S OKUMURA K
Citation: F. Komada et al., EFFECT OF TRANSFECTION WITH SUPEROXIDE-DISMUTASE EXPRESSION PLASMID ON SUPEROXIDE ANION-INDUCED CYTOTOXICITY IN CULTURED RAT LUNG-CELLS, Biological & pharmaceutical bulletin, 19(2), 1996, pp. 274-279
EFFECT OF CYCLOSPORINE ANALOGS AND FK506 ON TRANSCELLULAR TRANSPORT OF DAUNORUBICIN AND VINBLASTINE VIA P-GLYCOPROTEIN
Authors: TANAKA K HIRAI M TANIGAWARA Y YASUHARA M HORI R UEDA K INUI K
Citation: K. Tanaka et al., EFFECT OF CYCLOSPORINE ANALOGS AND FK506 ON TRANSCELLULAR TRANSPORT OF DAUNORUBICIN AND VINBLASTINE VIA P-GLYCOPROTEIN, Pharmaceutical research, 13(7), 1996, pp. 1073-1077
EFFECTS OF TRANSFECTION WITH THE CU,ZN-SUPEROXIDE DISMUTASE GENE ON XANTHINE XANTHINE OXIDASE-INDUCED CYTOTOXICITY IN FIBROBLASTS FROM RAT SKIN
Authors: NISHIGUCHI K ISHIDA K NAKAJIMA M MAEDA T KOMADA F IWAKAWA S TANIGAWARA Y OKUMURA K
Citation: K. Nishiguchi et al., EFFECTS OF TRANSFECTION WITH THE CU,ZN-SUPEROXIDE DISMUTASE GENE ON XANTHINE XANTHINE OXIDASE-INDUCED CYTOTOXICITY IN FIBROBLASTS FROM RAT SKIN, Pharmaceutical research, 13(4), 1996, pp. 577-582
PREMARKETING POPULATION PHARMACOKINETIC STUDY OF LEVOFLOXACIN IN NORMAL SUBJECTS AND PATIENTS WITH INFECTIOUS-DISEASES
Authors: TANIGAWARA Y NOMURA H KAGIMOTO N OKUMURA K HORI R
Citation: Y. Tanigawara et al., PREMARKETING POPULATION PHARMACOKINETIC STUDY OF LEVOFLOXACIN IN NORMAL SUBJECTS AND PATIENTS WITH INFECTIOUS-DISEASES, Biological & pharmaceutical bulletin, 18(2), 1995, pp. 315-320
POPULATION PHARMACOKINETICS OF THEOPHYLLINE .3. PREMARKETING STUDY FOR A ONCE-DAILY ADMINISTERED PREPARATION
Authors: TANIGAWARA Y KOMADA F SHIMIZU T IWAKAWA S IWAI T MAEKAWA H HORI R OKUMURA K
Citation: Y. Tanigawara et al., POPULATION PHARMACOKINETICS OF THEOPHYLLINE .3. PREMARKETING STUDY FOR A ONCE-DAILY ADMINISTERED PREPARATION, Biological & pharmaceutical bulletin, 18(11), 1995, pp. 1590-1598
CEPHARANTHIN, A MULTIDRUG-RESISTANT MODIFIER, IS A SUBSTRATE FOR P-GLYCOPROTEIN
Authors: HIRAI M TANAKA K SHIMIZU T TANIGAWARA Y YASUHARA M HORI R KAKEHI Y YOSHIDA O UEDA K KOMANO T INUI KI
Citation: M. Hirai et al., CEPHARANTHIN, A MULTIDRUG-RESISTANT MODIFIER, IS A SUBSTRATE FOR P-GLYCOPROTEIN, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 73-78
POPULATION ANALYSIS OF THE DOSE-DEPENDENT PHARMACOKINETICS OF ZONISAMIDE IN EPILEPTIC PATIENTS
Authors: HASHIMOTO Y ODANI A TANIGAWARA Y YASUHARA M OKUNO T HORI R
Citation: Y. Hashimoto et al., POPULATION ANALYSIS OF THE DOSE-DEPENDENT PHARMACOKINETICS OF ZONISAMIDE IN EPILEPTIC PATIENTS, Biological & pharmaceutical bulletin, 17(2), 1994, pp. 323-326
PREDICTIVE PERFORMANCE OF THE BAYESIAN-ANALYSIS - EFFECTS OF BLOOD-SAMPLING TIME, POPULATION PARAMETERS, AND PHARMACOSTATISTICAL MODEL
Authors: TANIGAWARA Y YANO I KAWAKATSU K NISHIMURA K YASUHARA M HORI R
Citation: Y. Tanigawara et al., PREDICTIVE PERFORMANCE OF THE BAYESIAN-ANALYSIS - EFFECTS OF BLOOD-SAMPLING TIME, POPULATION PARAMETERS, AND PHARMACOSTATISTICAL MODEL, Journal of pharmacokinetics and biopharmaceutics, 22(1), 1994, pp. 59-71
RENAL HANDLING OF TOBRAMYCIN IN THE ISOLATED-PERFUSED RAT-KIDNEY
Authors: AIBA T ITOGA Y SHIMIZU H TANIGAWARA Y HORI R
Citation: T. Aiba et al., RENAL HANDLING OF TOBRAMYCIN IN THE ISOLATED-PERFUSED RAT-KIDNEY, Journal of pharmaceutical sciences, 83(5), 1994, pp. 723-726
HUMAN P-GLYCOPROTEIN AS A MULTIDRUG TRANSPORTER ANALYZED BY USING TRANSEPITHELIAL TRANSPORT-SYSTEM
Authors: UEDA K SAEKI T HIRAI M TANIGAWARA Y TANAKA K OKAMURA M YASUHARA M HORI R INUI K KOMANO T
Citation: K. Ueda et al., HUMAN P-GLYCOPROTEIN AS A MULTIDRUG TRANSPORTER ANALYZED BY USING TRANSEPITHELIAL TRANSPORT-SYSTEM, Japanese Journal of Physiology, 44, 1994, pp. 67-71
POPULATION PHARMACOKINETICS OF THEOPHYLLINE .2. INTRAVENOUS-INFUSION TO PATIENTS WITH STABLE CHRONIC AIRWAY-OBSTRUCTION
Authors: YANO I TANIGAWARA Y YASUHARA M OKUMURA K KAWAKATSU K NISHIMURA K HORI R
Citation: I. Yano et al., POPULATION PHARMACOKINETICS OF THEOPHYLLINE .2. INTRAVENOUS-INFUSION TO PATIENTS WITH STABLE CHRONIC AIRWAY-OBSTRUCTION, Biological & pharmaceutical bulletin, 16(5), 1993, pp. 501-505
DIGOXIN-CYCLOSPORINE A-INTERACTION - MODULATION OF THE MULTIDRUG TRANSPORTER P-GLYCOPROTEIN IN THE KIDNEY
Authors: OKAMURA N HIRAI M TANIGAWARA Y TANAKA K YASUHARA M UEDA K KOMANO T HORI R
Citation: N. Okamura et al., DIGOXIN-CYCLOSPORINE A-INTERACTION - MODULATION OF THE MULTIDRUG TRANSPORTER P-GLYCOPROTEIN IN THE KIDNEY, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1614-1619
ROLE OF P-GLYCOPROTEIN IN RENAL TUBULAR SECRETION OF DIGOXIN IN THE ISOLATED-PERFUSED RAT-KIDNEY
Authors: HORI R OKAMURA N AIBA T TANIGAWARA Y
Citation: R. Hori et al., ROLE OF P-GLYCOPROTEIN IN RENAL TUBULAR SECRETION OF DIGOXIN IN THE ISOLATED-PERFUSED RAT-KIDNEY, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1620-1625
P-GLYCOPROTEIN-MEDIATED TRANSCELLULAR TRANSPORT OF MDR-REVERSING AGENTS
Authors: SAEKI T UEDA K TANIGAWARA Y HORI R KOMANO T
Citation: T. Saeki et al., P-GLYCOPROTEIN-MEDIATED TRANSCELLULAR TRANSPORT OF MDR-REVERSING AGENTS, FEBS letters, 324(1), 1993, pp. 99-102
Risultati: 1-24 |